Elevation Oncology Stock Forward View
| ELEVDelisted Stock | USD 0.37 0.00 0.00% |
Elevation Stock outlook is based on your current time horizon.
At this time the value of rsi of Elevation Oncology's share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Elevation Oncology hype-based prediction, you can estimate the value of Elevation Oncology from the perspective of Elevation Oncology response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Elevation Oncology on the next trading day is expected to be 0.39 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.82. Elevation Oncology after-hype prediction price | USD 0.37 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Elevation |
Elevation Oncology Additional Predictive Modules
Most predictive techniques to examine Elevation price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Elevation using various technical indicators. When you analyze Elevation charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Elevation Oncology Naive Prediction Price Forecast For the 6th of February
Given 90 days horizon, the Naive Prediction forecasted value of Elevation Oncology on the next trading day is expected to be 0.39 with a mean absolute deviation of 0.01, mean absolute percentage error of 0.0003, and the sum of the absolute errors of 0.82.Please note that although there have been many attempts to predict Elevation Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Elevation Oncology's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Elevation Oncology Stock Forecast Pattern
| Backtest Elevation Oncology | Elevation Oncology Price Prediction | Research Analysis |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Elevation Oncology stock data series using in forecasting. Note that when a statistical model is used to represent Elevation Oncology stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 109.9159 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0135 |
| MAPE | Mean absolute percentage error | 0.0393 |
| SAE | Sum of the absolute errors | 0.8218 |
Predictive Modules for Elevation Oncology
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Elevation Oncology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Elevation Oncology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Elevation Oncology After-Hype Price Density Analysis
As far as predicting the price of Elevation Oncology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Elevation Oncology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Elevation Oncology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Elevation Oncology Estimiated After-Hype Price Volatility
In the context of predicting Elevation Oncology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Elevation Oncology's historical news coverage. Elevation Oncology's after-hype downside and upside margins for the prediction period are 0.37 and 0.37, respectively. We have considered Elevation Oncology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Elevation Oncology is very steady at this time. Analysis and calculation of next after-hype price of Elevation Oncology is based on 3 months time horizon.
Elevation Oncology Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Elevation Oncology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Elevation Oncology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Elevation Oncology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 6 Events / Month | 3 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.37 | 0.37 | 0.00 |
|
Elevation Oncology Hype Timeline
Elevation Oncology is currently traded for 0.37. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Elevation is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Elevation Oncology is about 0.0%, with the expected price after the next announcement by competition of 0.37. About 60.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.46. Some equities with similar Price to Book (P/B) outperform the market in the long run. Elevation Oncology recorded a loss per share of 0.81. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 6 days. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services.Elevation Oncology Related Hype Analysis
Having access to credible news sources related to Elevation Oncology's direct competition is more important than ever and may enhance your ability to predict Elevation Oncology's future price movements. Getting to know how Elevation Oncology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Elevation Oncology may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MTVA | MetaVia | (0.40) | 8 per month | 0.00 | (0.18) | 11.60 | (20.10) | 79.95 | |
| MEIP | MEI Pharma | (0.07) | 8 per month | 7.01 | 0.1 | 11.67 | (11.72) | 60.63 | |
| TRAW | Traws Pharma | (0.13) | 10 per month | 8.74 | (0) | 17.70 | (12.90) | 58.96 | |
| KA | Kineta Inc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PHXM | PHAXIAM Therapeutics SA | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| RNLX | Renalytix AI | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ANPC | Anpac Bio Medical | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PIRS | Pieris Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DOMH | Dominari Holdings | 0.31 | 6 per month | 0.00 | (0.05) | 5.71 | (7.43) | 24.67 | |
| LSB | LakeShore Biopharma Co | (0.03) | 7 per month | 8.14 | 0.01 | 12.33 | (12.50) | 91.99 |
Elevation Oncology Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Elevation Oncology stock to make a market-neutral strategy. Peer analysis of Elevation Oncology could also be used in its relative valuation, which is a method of valuing Elevation Oncology by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Elevation Oncology Market Strength Events
Market strength indicators help investors to evaluate how Elevation Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Elevation Oncology shares will generate the highest return on investment. By undertsting and applying Elevation Oncology stock market strength indicators, traders can identify Elevation Oncology entry and exit signals to maximize returns.
| Accumulation Distribution | 0.0789 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 0.37 | |||
| Day Typical Price | 0.37 | |||
| Market Facilitation Index | 0.03 | |||
| Price Action Indicator | 0.005 |
Elevation Oncology Risk Indicators
The analysis of Elevation Oncology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Elevation Oncology's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting elevation stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.37 | |||
| Semi Deviation | 3.35 | |||
| Standard Deviation | 5.45 | |||
| Variance | 29.65 | |||
| Downside Variance | 24.12 | |||
| Semi Variance | 11.22 | |||
| Expected Short fall | (6.16) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Elevation Oncology
The number of cover stories for Elevation Oncology depends on current market conditions and Elevation Oncology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Elevation Oncology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Elevation Oncology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Elevation Oncology Short Properties
Elevation Oncology's future price predictability will typically decrease when Elevation Oncology's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Elevation Oncology often depends not only on the future outlook of the potential Elevation Oncology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Elevation Oncology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 57.3 M | |
| Cash And Short Term Investments | 93.2 M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Elevation Stock
If you are still planning to invest in Elevation Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Elevation Oncology's history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |